CD8A and breast carcinoma: Besides its common function in adipogenesis and lipid metabolism [68], PPARv has been linked to worse outcomes in breast cancer patients [69,70], as well as the evasion of immunosurveillance and the impairment of CD8 T-cell infiltration in muscle-invasive bladder cancer [71].